Hostname: page-component-84b7d79bbc-4hvwz Total loading time: 0 Render date: 2024-07-26T15:14:45.110Z Has data issue: false hasContentIssue false
  • English
  • Français

Developing the evidence base for the new guidelines for reduction of cardiovascular risk for children by the National Heart, Lung, and Blood Institute

Published online by Cambridge University Press:  13 December 2011

Samuel S. Gidding
Samuel S. Gidding*
Affiliation:
Nemours Cardiac Center, A. I. DuPont Hospital for Children, 1600 Rockland Road, Wilmington, Delaware, United States of America
*
Correspondence to: Dr Samuel S. Gidding, MD, Nemours Cardiac Center, 1600 Rockland Road, Wilmington, Delaware 19803, United States of America. Tel: +1 302 651 6639; Fax: +1 302 651 5345; E-mail: sgidding@nemours.org
Get access Rights & Permissions [Opens in a new window]

Abstract

In 2006, a process was initiated to develop evidence-based paediatric guidelines directed towards physicians for reduction of cardiovascular risk. In contrast to prior consensus-based guidelines from the National Heart, Lung, and Blood Institute, this process was to be evidenced based. This manuscript describes the process undertaken to write the evidence-based guidelines from the National Heart, Lung, and Blood Institute, beginning with the search for evidence, then the process of review of the evidence, and finally the writing of the final document. This manuscript also provides some thoughts on how this process might be adapted in developing guidelines for caring for patients with congenital cardiac disease.

Keywords

guidelinesevidence-based medicinecardiovascular risk factorscongenital cardiac disease
Type
Original Article
Information
Cardiology in the Young , Volume 21 , Issue S2: A Holistic Approach to Hypoplastic Left Heart Syndrome and other evolving challenges in Pediatric and Congenital Cardiac Disease , 13 December 2011 , pp. 165 - 168
Copyright
Copyright © Cambridge University Press 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 1992; 89: 495–501.Google Scholar
2.National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114 (2 Suppl) 4th Report: 555–576.CrossRefGoogle Scholar
3.American Academy of Pediatrics Steering Committee on Quality Improvement and Management. Classifying recommendations for clinical practice guidelines. Pediatrics 2004; 114: 874–877.CrossRefGoogle Scholar
4.Davey Smith, G, et al. Challenges and novel approaches in the epidemiological study of early life influences on later disease. Adv Exp Med Biol 2009; 646: 1–14.CrossRefGoogle ScholarPubMed
5.Gidding, SS. Assembling evidence to justify prevention of atherosclerosis beginning in youth. Circulation 2010; 122: 2493–2494.CrossRefGoogle ScholarPubMed
6.Gidding, SS. The importance of randomized controlled trials in pediatric cardiology. JAMA 2007; 298: 1214–1216.CrossRefGoogle ScholarPubMed